Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
Finsterer
Josef
J
Frank
Marlies
M
Krexner
Elisabeth
E
D000368:Aged; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009157:Myasthenia Gravis / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D001379:Azathioprine